Eric Walton

Title: Eric Walton: Innovator in Cardiac Treatment

Introduction

Eric Walton is a notable inventor based in Wrotham, GB. He has made significant contributions to the field of cardiac treatment through his innovative research and development of pharmaceutical compounds. With a total of 2 patents, Walton's work focuses on addressing serious heart conditions.

Latest Patents

Walton's latest patents include "Substituted guanidine compounds in the treating of arrhythmias - N-substituted-guanidines having antifibrillatory activity; non-toxic salts thereof; pharmaceutical compositions thereof; and their use in treating cardiac fibrillations." This patent highlights the potential of these compounds in treating cardiac fibrillations effectively. Another significant patent is "Substituted guanidine compounds as antifibrillatory agents - Acid addition salts of N-p-methylbenzyl-N',N'-dimethylguanidine and of N-p-methoxybenzyl-N',N'-dimethylguanidine." These compounds exhibit antiarrhythmic properties and are specifically useful as antifibrillatory agents.

Career Highlights

Eric Walton is currently associated with Burroughs Wellcome Co., where he continues to advance his research in the pharmaceutical field. His work has been instrumental in developing new treatments that can significantly improve patient outcomes in cardiac health.

Collaborations

Walton collaborates with Robert Arthur Maxwell, contributing to the innovative research environment at Burroughs Wellcome Co. Their combined expertise enhances the development of effective cardiac treatments.

Conclusion

Eric Walton's contributions to cardiac treatment through his innovative patents demonstrate his commitment to improving healthcare. His work continues to pave the way for advancements in the treatment of arrhythmias and related conditions.